Informazione:
Errore:
Keywords
Adaptabilidade ×
- Clinical Trial (27)
- Adverse event (13)
- Hematology (13)
- Multiple Myeloma (13)
- Vital Signs (12)
- Drugs, Investigational (8)
- Concomitant Medication (8)
- Physical Examination (5)
- Pregnancy Tests (4)
- Urinalysis (4)
- Blood Coagulation (4)
- Clinical Chemistry Tests (4)
- Premature Ejaculation (4)
- Electrocardiogram (ECG) (4)
- Electrolytes (4)
- Disease Response (3)
- Pharmacogenetics (2)
- Asthma (2)
- Pulmonary Medicine (2)
- Biological Markers (2)
- Clinical Trial, Phase III (2)
- Neurology (2)
- Pharmacokinetics (1)
- Pregnancy (1)
- Psychotherapy (1)
- Quality of Life (1)
- Rhinitis, Allergic, Perennial (1)
- Virology (1)
- HIV Infections (1)
- Clinical Trial, Phase IV (1)
- Haemophilus influenzae type b (1)
- Pulmonary Disease, Chronic Obstructive (1)
- Nasal Sprays (1)
- Chest X- ray (1)
- Death (1)
- Double-Blind Method (1)
- Epilepsy (1)
- Glucocorticoids (1)
- Herpes Genitalis (1)
- Immunization, Secondary (1)
- Levodopa (1)
- Medical Oncology (1)
- Neisseria meningitidis (1)
- Parkinson Disease (1)
- Patient Compliance (1)
- Patient Participation (1)
Sommario
Modelli di dati selezionati
Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi
28 Risultati di ricerca.
Itemgroups: DCP Template Header, Compliance, DCP Template Footer
Itemgroups: Administrative, Diary - Target Day 1, Diary - Target Day 2, Diary Day 2, Target Day 3, Diary Day 3, Investigational Product - Study drug returned, Additional bottle(s) returned, Investigational Product - Study drug dispensed , Additional bottle(s) dispensed , Study Drug Compliance, L-Dopa Medication
Itemgroups: Administrative, Visit Date, Vital Signs, SRT501 Administration, Study Treatment Compliance (Issue), New Adverse Events and Concomitant Treatment
Itemgroups: Administrative, Visit Date, Vital Signs, SRT501 Administration, Study Treatment Compliance (Issue), New Adverse Events and Concomitant Treatment
Itemgroups: Administrative, Visit Date, Was a physical examination performed?, Physical Examination, Vital Signs, 12-Lead ECG, ECG Results, ECG Findings, Hematology, Hematology , Clinical Chemistry, Coagulation and Electrolytes, Clinical Chemistry, Coagulation and Electrolytes , Urinalysis dipstick results, Urinalysis microscopy results, Urinalysis microscopy results , Serum beta-hCG Pregnancy Test, PK Sampling - Plasma Samples, Study Treatment Compliance (Return) , New Adverse Events and Concomitant Treatment
Itemgroups: Administrative, Vital Signs, SRT501 Administration, Study Treatment Compliance (Issue), New Adverse Events and Concomitant Treatment
Itemgroups: Administrative, Visit Date, PK Sampling - Plasma Samples, SRT501 Administration, Study Treatment Compliance (Return), New Adverse Events and Concomitant Treatment
Itemgroups: Administrative, Visit Date, PK Sampling - Plasma Samples, SRT501 Administration, Study Treatment Compliance (Return), New Adverse Events and Concomitant Treatment
Itemgroups: Administrative, Vital Signs, Physical Examination, Physical Examination - Changes, Neurological Examination, Neurological Examination, Haematology , Clinical Chemistry , Plasma Concentrations of AEDs , Compliance Record, Quality of Life, Global Evaluation
Itemgroups: Death, Study Conclusion, Pharmacogenetic Research Withdrawal of Consent, Pregnancy Information, Investigational Product Discontinuation, Investigational Product Compliance, Log Status
ItemGroup: Therapist questions
Patient Version
1 ItemGroup 19 elementi Itemgroups: Administrative, Visit Date, Was a physical examination performed?, Physical Examination, Vital Signs, 12-Lead ECG, ECG Result, ECG Findings, Hematology, Hematology , Clinical Chemistry, Coagulation and Electrolytes, Clinical Chemistry, Coagulation and Electrolytes , Urinalysis dipstick results, Urinalysis microscopy results, Urinalysis microscopy results , Serum beta-hCG Pregnancy Test, Radiographic Assessment, Radiographic Assessment , Disease Marker Assessment , Disease Marker Assessment , Disease Response, Study Treatment Compliance (Return) , New Adverse Events and Concomitant Treatment